Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Inflammatory bowel disease and the heart: how trained immunity shapes cardiovascular outcomes.

Created on 03 Nov 2026

Authors

Shuanghua Liang, Long Han

Published in

Frontiers in immunology. Volume 17. Pages 1935682. Epub Oct 19, 2026.

Abstract

Inflammatory bowel disease (IBD), comprising Crohn's disease and ulcerative colitis, is a chronic relapsing intestinal inflammatory disorder. Cardiovascular disease (CVD) is a leading cause of death in patients with IBD, with elevated risks of myocardial infarction, heart failure, stroke, and venous thromboembolism that are independent of traditional risk factors. Disease activity and histological inflammation independently predict major adverse cardiovascular events, and Crohn's disease and ulcerative colitis differ in cardiovascular risk profiles. This residual risk points to immune mechanisms that remain unclear. Trained immunity (TI), an innate immune memory induced by epigenetic and metabolic reprogramming, may link chronic intestinal inflammation to cardiovascular injury. This review integrates epidemiological and mechanistic evidence, outlines cardiovascular risk features in IBD, examines the molecular basis of TI and its roles in atherosclerosis, myocardial injury, and heart failure, and evaluates candidate biomarkers and targeted therapeutic strategies. We also discuss current limitations and challenges in clinical translation and propose future research directions, to inform mechanistic studies and clinical interventions for IBD-associated CVD.

PMID:
42974200
Bibliographic data and abstract were imported from PubMed on 03 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement